Stefanie S. Schalm

5.3k citations
19 papers · 2.0k indexed · 1 hit paper · h-index 13
    • PI3K/AKT/mTOR signaling in cancer 5
    • Cancer therapeutics and mechanisms 3
    • Protein Kinase Regulation and GTPase Signaling 3
    • Epigenetics and DNA Methylation 2
    • RNA modifications and cancer 2
  • Oncology top 10%
    • Colorectal Cancer Treatments and Studies 4
    • Lung Cancer Research Studies 3
  • Genetics top 10%
    • Lung Cancer Treatments and Mutations 7

Stefanie S. Schalm

19 papers receiving 2.0k citations

Hit Papers

The landscape of kinase fusions in cancer6572014202620182022200400600

Peers

Stefanie S. Schalm
Comparison fields: 5 of 92
  • Molecular Biology 1.5k
  • Cancer Research 309
  • Oncology 428
  • Genetics 157
  • Pulmonary and Respiratory Medicine 387
Replace Kiran Mahajan with:
Kiran Mahajan United States
Yoon Jong Choi United States
Katti Jessen United States
Karl Dykema United States
Esther Castellano Spain
Rachel A. Altura United States
Qunsheng Ji China
Thomas Hattier United States
Janiel M. Shields United States
Andrea Lunardi United States
Stefanie S. Schalm relative to Kiran Mahajan United States Kiran Mahajan's profile →
Citations per field
00.5×1.5×2.0×
Kiran Mahajan · 1×
Citations per year

Countries citing papers authored by Stefanie S. Schalm

Since Specialization
Citations

This map shows the geographic impact of Stefanie S. Schalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie S. Schalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie S. Schalm more than expected).

Fields of papers citing papers by Stefanie S. Schalm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie S. Schalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie S. Schalm. The network helps show where Stefanie S. Schalm may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stefanie S. Schalm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stefanie S. Schalm Line = papers co-authored together Stefanie S. Schalm links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20247
2 20231
3 20229
4 20229
5 202117
6 202043
7 202012
8 20151
9
The landscape of kinase fusions in cancerbreakdown →
2014657
10 2014128
11 20141
12 201050
13 201035
14 200545
15 2004111
16 2003395
17 2002364
18 200153
19 200157

About Stefanie S. Schalm

Stefanie S. Schalm is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 19 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Research Studies (3 papers), Cancer therapeutics and mechanisms (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Epigenetics and DNA Methylation (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Molecular Biology (1.5k citations), Cancer Research (309 citations) and Oncology (428 citations). Stefanie S. Schalm has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include John Blenis, Joseph L. Kim, Ethan Cerami, Nicolas Stransky, Christoph Lengauer, David M. Sabatini, Diane C. Fingar, Celeste Richardson, Sean M. Buchanan and Tom Maniatis. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026